As of 2025-07-01, the Relative Valuation of Cogent Biosciences Inc (COGT) is (66.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.18 USD, the upside of Cogent Biosciences Inc based on Relative Valuation is -1023.1%.
The range of the Relative Valuation is (55.96) - (92.24) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.2x - 38.9x | 25.3x |
| Forward P/E multiples | 23.6x - 46.5x | 30.6x |
| Fair Price | (55.96) - (92.24) | (66.28) |
| Upside | -879.4% - -1384.7% | -1023.1% |
| Date | P/E |
| 2025-06-26 | -3.09 |
| 2025-06-25 | -2.98 |
| 2025-06-24 | -3.05 |
| 2025-06-23 | -3.06 |
| 2025-06-20 | -3.05 |
| 2025-06-18 | -3.05 |
| 2025-06-17 | -3.21 |
| 2025-06-16 | -3.16 |
| 2025-06-13 | -2.99 |
| 2025-06-12 | -3.04 |
| 2025-06-11 | -3.06 |
| 2025-06-10 | -3.13 |
| 2025-06-09 | -2.91 |
| 2025-06-06 | -2.87 |
| 2025-06-05 | -2.53 |
| 2025-06-04 | -2.38 |
| 2025-06-03 | -2.44 |
| 2025-06-02 | -2.37 |
| 2025-05-30 | -2.29 |
| 2025-05-29 | -2.32 |
| 2025-05-28 | -2.06 |
| 2025-05-27 | -2.06 |
| 2025-05-23 | -2.03 |
| 2025-05-22 | -2.09 |
| 2025-05-21 | -2.10 |
| 2025-05-20 | -2.24 |
| 2025-05-19 | -2.10 |
| 2025-05-16 | -2.06 |
| 2025-05-15 | -2.01 |
| 2025-05-14 | -2.06 |
| 2025-05-13 | -2.10 |
| 2025-05-12 | -2.16 |
| 2025-05-09 | -2.03 |
| 2025-05-08 | -2.10 |
| 2025-05-07 | -1.99 |
| 2025-05-06 | -1.98 |
| 2025-05-05 | -2.35 |
| 2025-05-02 | -2.48 |
| 2025-05-01 | -2.37 |
| 2025-04-30 | -2.20 |
| 2025-04-29 | -2.12 |
| 2025-04-28 | -2.07 |
| 2025-04-25 | -1.96 |
| 2025-04-24 | -1.90 |
| 2025-04-23 | -1.89 |
| 2025-04-22 | -1.83 |
| 2025-04-21 | -1.81 |
| 2025-04-17 | -1.84 |
| 2025-04-16 | -1.80 |
| 2025-04-15 | -2.05 |